Old Web
English
Sign In
Acemap
>
authorDetail
>
Alain Munafo
Alain Munafo
Merck & Co.
Multiple sclerosis
Cladribine
Medicine
Internal medicine
Population
5
Papers
37
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Effects of Postponing Treatment in the Second Year of Cladribine Administration: Clinical Trial Simulation Analysis of Absolute Lymphocyte Counts and Relapse Rate in Patients with Relapsing-Remitting Multiple Sclerosis
2019
Clinical Pharmacokinectics
Nadia Terranova
Christine Hicking
Fernando Dangond
Alain Munafo
Show All
Source
Cite
Save
Citations (7)
Efficacy, safety and population pharmacokinetics of sapropterin in PKU patients <4 years: results from the SPARK open-label, multicentre, randomized phase IIIb trial
2017
Orphanet Journal of Rare Diseases
Ania C. Muntau
Alberto Burlina
François Eyskens
Peter Freisinger
Corinne De Laet
Vincenzo Leuzzi
Frank Rutsch
H. Serap Sivri
Suresh Vijay
Milva Bal
Gwendolyn Gramer
Renata Pazdírková
Maureen Cleary
Amelie S. Lotz-Havla
Alain Munafo
Diane R. Mould
Flavie Moreau-Stucker
Daniela Rogoff
Show All
Source
Cite
Save
Citations (13)
Population Pharmacokinetics of Cladribine in Patients with Multiple Sclerosis
2017
Clinical Pharmacokinectics
Radojka M. Savic
Ana M. Novakovic
Marianne Ekblom
Alain Munafo
Mats O Karlsson
Show All
Source
Cite
Save
Citations (15)
1